EDITORIAL SECTION

Articles

The 2025 Agenda: Navigating New European Compliance Challenges in Pharma

EU pharma industry expectate new regulations changes in the year European Medicines Agency EMA and other regulatory authorities in the continent gradually increase regulatory requirements that exercise greater pressure on business entities to implement patientoriented sustainable and innovative production standards

Digital Twins: The Future Blueprint for Pharmaceutical Production

Digital Twins have revolutionized the pharmaceutical industry by providing virtual replicas of physical assets and processes This innovative technology offers a comprehensive view of manufacturing

Risk Management in Pharmaceutical Manufacturing

The pharmaceutical industry operates under strict regulatory oversight because medicines directly affect patient health and safety Manufacturers must consistently produce products that meet predefined standards of quality safety efficacy identity strength and purity Achieving these objectives requires a proactive approach to identifying and controlling risks throughout the product lifecycle

From Molecule to Market: Building a Regulatory-Ready Manufacturing Strategy

Every pharmaceutical executive can recite the journey from molecule to market Far fewer can say with confidence at which point in that journey their manufacturing strategy became capable of withstanding a regulatory inspection The distinction matters more than it once did Approval timelines are compressing

Biopharmaceutical Facility Design for Sustainability: A Comprehensive Overview

The design and operation of biopharmaceutical facilities play a pivotal role in shaping the environmental impact of the pharmaceutical industry In recent years there has been a growing emphasis on sustainability within this sector

Virtual Webinars for Pharma Lead Generation: B2B Strategies 2026

In the changing environment of pharmaceutical marketing digital interactions have acquired the first place Although traditional facetoface conferences and trade show remain important virtual conferences are replacing them and at times complementing them Of them the pharma webinars have proven to be an effective approach to BB lead generation so pharmaceutical companies can connect with the audienc...

Techno Trends

Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein

Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue

Projects

SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing

SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more

Research Insights

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys